Search For "bharat biotech"
PM Modi visits Bharat Biotech vaccine facility, Zydus Biotech Park
Updated : 5 years, 3 months ago IST
Hyderabad (Telangana) [India], November 28 (ANI): Prime Minister Narendra Modi on Saturday visited the manufacturing facility of Bharat Biotech International Limited (BBIL) in Telangana to review the development of its 'Covaxin' Covid-19 vaccine candidate.
Read More
PM Modi concludes Zydus Biotech Park visit, next stop Bharat Biotech facil
Updated : 5 years, 3 months ago IST
Ahmedabad (Gujarat) [India], November 28 (ANI): Prime Minister Narendra Modi on Saturday concluded his visit to Zydus Biotech Park in Ahmedabad after reviewing the development of COVID-19 vaccine candidate ZyCOV-D.
Read More
PM Modi to visit vaccine making units in Ahmedabad, Hyderabad, Pune today
Updated : 5 years, 3 months ago IST
New Delhi [India], November 28 (ANI): Prime Minister Narendra Modi on Saturday will embark on a three-city visit to personally review the vaccine development and manufacturing process.
Read More
COVID-19: Haryana announces closure of schools till November 30
Updated : 5 years, 4 months ago IST
Chandigarh [India], November 20 (ANI): All government and private schools in Haryana will remain closed till November 30 in view of COVID-19 situation, the state government said on Friday.
Read More
Haryana Health Minister Anil Vij administered trial dose of Covaxin
Updated : 5 years, 4 months ago IST
Ambala (Haryana) [India], November 20 (ANI): Haryana Health Minister Anil Vij was administered a trial dose of Bharat Biotech's COVID-19 vaccine 'Covaxin' at a hospital in Ambala on Friday.
Read More
Hoping to get 1000 volunteers for Covaxin trial, says PGIMS V-C
Updated : 5 years, 4 months ago IST
Rohtak (Haryana) [India], November 19 (ANI): Pandit Bhagwat Dayal Sharma Post Graduate Institute of Medical Sciences (PGIMS), Rohtak, hopes to get 1,000 healthy volunteers by Thursday for the third-phase trial of Bharat Biotech's COVID-19 vaccine candidate, Covaxin, that will begin from F
Read More
Anil Vij offers to be 'first volunteer' for Phase-III trial of Covaxin in
Updated : 5 years, 4 months ago IST
New Delhi [India], November 18 (ANI): Haryana Health Minister Anil Vij has offered to become the "first volunteer" for Phase-III clinical trial of Bharat Biotech's COVID-19 vaccine 'Covaxin', which will begin in Haryana from November 20.
Read More
Bharat Biotech starts phase III trials for COVAXIN
Updated : 5 years, 4 months ago IST
Hyderabad [India], November 17, (ANI): Bharat Biotech announced the commencement of Phase III trials of COVAXIN on Monday.
Read More
Bharat Biotech to manufacture 10 types of vaccines, including COVID-19, in
Updated : 5 years, 4 months ago IST
Bhubaneswar (Odisha) [India], November 7 (ANI): Bharat Biotech International Ltd (BBIL) is going to manufacture ten types of vaccines including malaria and the novel coronavirus in its upcoming unit here, Chairman and Managing Director Dr. Krishna Ella said while attending a virtual meeti
Read More
DCGI gives nod for phase 3 trial of Bharat Biotech's COVID-19 vaccine
Updated : 5 years, 5 months ago IST
New Delhi [India], October 23 (ANI): In a major development, Drugs Controller General of India (DCGI) on Friday gave permission to Bharat Biotech for conducting Phase-III clinical trial for the indigenous COVID-19 vaccine - Covaxin.
Read More
DCGI's expert panel recommends Phase 3 clinical trial nod for Bharat Biote
Updated : 5 years, 5 months ago IST
New Delhi [India], October 22 (ANI): The expert panel at Central Drugs Standard Control Organisation (CDSCO) has recommended the top drugs regulator to grant permission to Bharat Biotech to conduct phase III clinical trial using indigenous covid19 vaccine--Covaxin, with subject to the condit
Read More
Submit previous trial data for Covaxin before rolling out phase III: Drug
Updated : 5 years, 5 months ago IST
New Delhi [India], October 10 (ANI): The expert panel at Central Drugs Standard Control Organisation (CDSCO) has asked drug maker Bharat Biotech to submit safety and immunogenicity data from ongoing phase II trial in order to conduct phase III clinical trial of indigenous COVID-19 vaccine, C
Read More